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Administration of heat-killed Propionibacterium acnes renders mice highly susceptible to LPS. After LPS challenge P. acnes-
primed mice promptly show hypothermia, hypercoagulation (disseminated intravascular coagulation), elevation of serum
proinﬂammatory cytokine levels, and high mortality. The surviving mice develop liver injury. As previously reported, IL-18 plays a
pivotal role in the development of this liver injury. Many cell types including macrophages constitutively store IL-18 as biologically
inactive precursor (pro) form. Upon appropriate stimulation exempliﬁed by TLR4 engagement, the cells secrete biologically active
IL-18 by cleaving pro-IL-18 with caspase-1. Caspase-1 is also constitutively produced as a zymogen in macrophages. Recently,
NLRP3, a cytoplasmic pathogen sensor, has been demonstrated to be involved in the activation of caspase-1. Here, we review the
molecular mechanisms for the liver injuries, particularly focusing on the TLR4/NLRP3-mediated caspase-1 activation process,
with a brief introduction of the mechanism underlying P. acnes-induced sensitization to LPS.
1.Introduction
TLR, topics of this issue, is an extracellular sensor family
of pathogen-associated molecular patterns (PAMPs) [1, 2].
As described by Yamamoto et al. in this special issue,
TLR1, TLR2, TLR4, TLR5, TLR6, and TLR11 are expressed
on the cell surface, while TLR3, TLR7, TLR8, and TLR9
are expressed on the membrane of endosome, which is
a transport vesicle originated from the cell membrane to
trap and transport the extracellular macromolecules into
the inside of the cells. Besides, mammalian host possess
cytoplasmic sensors consisting of at least two families,
RIG-I-like receptor (RLR) and Nod-like receptor (NLR)
families [3–5]. After sensing intracellular, virus-derived
double-stranded (ds) RNA, RLR members relay a signal
to activate inﬂammatory responses for viral clearance via
induction of proinﬂammatory cytokines and type 1IFNs
[6, 7]. Some of the NLR family members are associated with
the cytoplasmic formation and activation of inﬂammasome.
Inﬂammasome is a multiple protein complex and is regarded
as the platform for activation of caspase-1 [8, 9]. Caspase-
1 is produced as enzymatically inactive precursors (pro) and
requiresappropriatecleavagetobecomeactive.Macrophages
including Kupﬀer cells constitutively produce procaspase-1
and accomplish caspase-1 activation in the inﬂammasomes
afterbeingstimulated[10–12].Caspase-1cleavesbiologically
inactive pro-IL-1β and pro-IL-18, leading to extracellular
release of the corresponding active forms. Many cell types
including Kupﬀer cells produce and store pro-IL-18 in the
steady state, while they start to produce pro-IL-1β only
after activation with appropriate stimuli [13–15]. Thus, the
inﬂammasomes contribute to the secretion of IL-18 and IL-
1β via activation of caspase-1.
Inﬂammasome is composed of certain member of NLR
and procaspase 1 [5, 8, 9] (Figure 1). NLR family members
are divided into two groups. One is an NLRP group
possessing pyrin domain (PYD), and the other is an NLRC
group lacking PYD but possessing caspase recruitment
domain (CARD) [19]. NLRP1 (Nalp1), NLRP3 (Nalp3),
and NLRC4 (Ipaf) have been demonstrated to nucleate the2 Gastroenterology Research and Practice
NLRP1 (Nalp1)
NLRP1
Pro-casp1
ASC
Pro-casp1
Pro-casp5
NLRP1 (Nalp1) NLRP3 (Nalp3) NLRC4 (Ipaf) AIM2
AIM2
Inﬂammasome
Pro-casp1
Pro-casp1
Pro-casp1
ASC
ASC
NLRP3 NLRC4
Nucleotide-binding domain (NBD)
Caspase recruitment domain (CARD)
Leucine rich repeat (LRR) domain
Pyrin domain (PyD)
Figure 1: Inﬂammasome constituents. There have been reported at least four types of inﬂammasomes, NLRP1 (Nalp1), NLRP3 (Nalp3),
NLRC4 (Ipaf), and AIM2 inﬂammasomes. NLR is subdivided into two groups, PYD-possessing group, namely, NLRP and PYD-lacking
group NLRC. After exposure of cells to the corresponding stimuli, these NLRs and AIM2 are believed to be self-oligomerized. As it contains
CARD at an N-terminus and PYD at a C-terminus, self-oligomerized NLRP1 can recruit procaspase (casp)-1 and procaspase-5 by action
of its CARD and also assembly procaspase-1 with help from ASC that possesses both PYD and CARD. Self-oligomerized NLRP3 recruits
procaspase-1byinterposingASCbetweenthem.Incontrast,self-oligomerizedNLRC4recruitsprocaspase-1bydirectlyinteractingCARDof
procaspase-1 with its CARD. AIM2, belonging a diﬀerent protein family, is also believed to be self-oligomerized after recognition of double-
stranded DNA and recruits procaspase-1 with help from ASC. NLR, Nod-like receptor; CARD, caspase recruitment domain; PYD, pyrin
domain.
NLRP3 inﬂammasome
Active caspase-1
Pro-IL-1β
Pro-IL-18
IL-1β
IL-18
Figure 2: A possible schema for IL-18/IL-1β processing by the
inﬂammasome. After appropriate stimulation, the NLRP3 inﬂam-
masome is activated to induce active caspase-1, which eventually
results in conversion of pro-IL-18/pro-IL-1β into biologically active
IL-18/IL-1β.
inﬂammasomes [5, 19]. In the inﬂammasome these NLRs
are believed to sense cytoplasmic PAMPs exempliﬁed by LPS
presumably via their leucine rich repeat (LRR) domain. LRR
domain of NLRP3 can recognize all of the TLR agonists
exceptforTLR5agonist,ﬂagellinofbacterialﬂagellum,while
that of NLRC4 senses ﬂagellin [20]. After being stimulated
the NLRs are self-oligomerized by binding each other using
their nucleotide-binding domain (NBD). Self-oligomerized
NLRP1directlyrecruitsprocaspase-1byhomophilicprotein-
protein interaction between its N-terminal CARD and
CARD of procaspase1 and/or procaspase-5 [8]. ASC con-
sisting of PYD and CARD is regarded as an adapter protein
for caspase-1 activation. The NLRP1 can bind to PYD
of ASC by its PYD domain at C-terminus, and CARD
of ASC eventually recruits procaspase-1 by CARD-CARD
interaction (Figure 1). The same scenario can be sketched
for the recruitment of procaspase-1 around the oligomerized
NLRP3-ASC complexes (Figure 1). NLRC4 has CARD
but not PYD. Upon appropriate stimulation of NLRC4,
procaspase-1 is recruited onto NLRC4 directly by CARD-
CARD interaction (Figure 1). Recently, AIM2, belonging to
ad i ﬀerent protein family namely PYHIN, was reported to
activate caspase-1 by sensing cytoplasmic ds-DNA [7, 21–
25]. After recognition of ds-DNA by HIN 200 domain
of it, AIM2 might be self-oligomerized for recruitment of
procaspase-1 by similarly interposing ASC between these
two proteins (Figure 1). Recruitment of procaspase-1 into
these inﬂammasomes is likely to activate caspase-1, leading
to conversion from pro-IL-18 and pro-IL-1β into active IL-
18 and IL-1β [26] (Figure 2).
As previously reported, mice having received heat-killed
Propionibacterium acnes are highly susceptible to LPS [27–
30]. P. acnes-primed mice suﬀer from liver injuries after LPS
challenge. However, administration of neutralizing anti-IL-
18 antibodies (Abs) just before LPS challenge can prevent P.
acnes-primedmicefromtheliverinjury[17].Besides,Il18−/−
mice are resistant to the P. acnes/LPS treatment [18]. Thus,
IL-18 is important for the development of liver injuries.Gastroenterology Research and Practice 3
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Figure 3: Kupﬀer cells promptly capture heat-killed P. acnes.C y 3 -
labeled,heat-killedP. acnes (red)wereadministeredintona¨ ıvewild-
type mice through a tail vein, and at 3h tissue specimens were
sampled. Frozen tissue slices were incubated with anti-F4/80mAb
(green) and DAPI for detecting macrophages and cell nuclei,
respectively. F4/80+ cells (Kupﬀer cells) capture P. acnes, while both
F4/80+ and F4/80
− cells ingest them in the spleen. In contrast
to live and spleen, both lung and kidney rarely contain P. acnes.
Magniﬁcation of insets is x800.
Here, we review the mechanisms for the P. acnes/LPS-
induced liver injuries, particularly focusing on those how
active IL-18 is released. Prior to addressing this, we would
like to introduce the cellular and molecular mechanisms
by which pretreatment with P. acnes render mice highly
susceptible to LPS.
2. Endotoxin Shock Syndrome in
P. acnes/LPS-TreatedMice
Hypothermia, hypercoagulation (disseminated intravascular
coagulation; DIC), high lethality, and tissue injuries are
major clinical manifestations of endotoxin shock syndrome
[30–35]. After challenge with a subclinical dose of LPS,
na¨ ıve wild-type (WT) mice do not show these signs
(Table 1). In contrast, mice having received heat-killed
P. acnes 7 days before are highly susceptible to LPS. P.
acnes-primed mice, but not na¨ ıve mice, show obvious and
gradual reduction of rectal temperature, serum elevation
of proinﬂammatory cytokines including IL-6, IFN-γ,a n d
TNF-α, high mortality and liver injuries after challenge
with the same subclinical dose of LPS [18, 30, 32]. LD50
to LPS in P. acnes- p r i m e dm i c ei sat h o u s a n d t ho rl e s so f
that in na¨ ıve mice [30]. Furthermore, they exhibit severe
hypercoagulationstatus,whichismonitoredbyplasmalevels
of coagulation indicator, thrombin antithrombin complexes
(TAT), and anti-ﬁbrinolytic protein, plasminogen activator
type 1 (PAI-1) that potently inhibits ﬁbrinolysis by blocking
conversion from plasminogen into ﬁbrinolytic plasmin [32,
36]. P. acnes-primed mice, but not na¨ ıve mice, tremendously
increase plasma levels of TAT and PAI-1 after LPS challenge
[32]. Thus, P. acnes treatment powerfully sensitizes mice to
LPS.
3. Kupffer Cell Ingestion of
Heat-killedP. acnes
P. acnes,aG r a m - p o s i t i v eb a c t e r i u m ,i so f t e nd e t e c t a b l eo n
human skin and has been believed to be relevant to various
inﬂammatory diseases, such as synovitis, acne, pustulosis,
hyperostosis, and osteitis (SAPHO) and sarcoidosis [37].
What happens in mice treated with heat-killed P. acnes?T o
address this, we labeled heat-killed P. acnes by Cy3, injected
them into WT mice through a tail vein, and sampled various
tissue specimens at 3 h. We examined tissue distribution of
Cy3+ particles by confocal microscopic analyses. Expectedly,
heat-killed P. acnes are accumulated in the liver and spleen,
whereas they were almost absent in the lung and kidney
(Figure 3). F4/80+ cells principally capture P. acnes in the
liver, while both F4/80− cells and F4/80+ cells ingest them
in the spleen (Figure 3).
At day 7 after P. acnes treatment tremendous hep-
atosplenomegaly is observed (Figure 4(a)). The liver doubles
its normal weight, whereas weight of spleen achieve more
than 5 times (Figure 4(b)). In contrast to the liver and
spleen, weight of kidney or lung remains unchanged. In the
liver, the dense granulomas primarily consisting of F4/80+
macrophages develop, in the center of which P. acnes-
ingested F4/80+ Kupﬀer cells are localized (Figure 4(c)),
suggesting that P. acnes-ingested F4/80+ Kupﬀer cells might
recruit many F4/80+ macrophages. Immunostaining using
rhodamine-conjugatedanti-F4/80mAbfollowedbycounter-
staining with hematoxylin reveals that abundant F4/80+
cells are present in the hepatic granulomas [38]. In con-
trast to the liver, obvious accumulation of F4/80+ cells
around P. acnes is absent in the spleen (Figure 4(c)).
Many dendritic cells were reported to compose the hepatic
granulomas as well [39, 40]. P. acnes treatment increases
hepatic F4/80+ cell number to 30 times and more of
that in na¨ ıve mice, while the splenic F4/80+ cell number
reaches only less than 5 times (Figure 4(d)). Furthermore,4 Gastroenterology Research and Practice
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Figure 4: Hepatosplenomegaly and hepatic granulomas in P. acnes-primed mice. Wild-type mice received Cy3-labeled, heat-killed P. acnes,
and at day 7 various tissues were removed and weighed (a, b). The liver slices were stained with anti-F4/80mAb and DAPI for detecting
macrophages and cell nuclei, respectively (c). Kupﬀer cells and splenocytes were prepared from P. acnes- p r i m e d( c l o s e d )o rn a ¨ ıve mice
(open).Afterstainingwith anti-F4/80mAb,proportionofF4/80+ cells were determined byFACS, andtotal F4/80+ cellnumberwascounted.
splenic macrophages from P. acnes-primed mice produce
much higher levels of proinﬂammatory cytokines including
TNF-α in response to LPS than do those from na¨ ıve
mice [32]. This is also the case for Kupﬀer cells. Thus,
P. acnes treatment induces both numerical increase and
qualitative alteration of macrophages in the liver and spleen.
This may implicate the importance of macrophages for
the accomplishment of the LPS sensitization by P. acnes
treatment.
4. Requirement of Macrophages for
the Sensitization to LPS Induced by
P. acnes Treatment
Depletion of macrophages rescues P. acnes-primed mice
from the liver injury and high mortality induced by the
subsequent challenge with LPS [38]( T a b l e1). This clearly
demonstrates the indispensability of macrophages for the P.
acnes-induced sensitization to LPS. Intravenous injection ofGastroenterology Research and Practice 5
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Figure 5: Molecular and cellular mechanisms underlying P. acnes-
induced sensitization to LPS. After recognition of heat-killed P.
acnes, cytoplasmic domain of TLR9 recruits MyD88 and relays
a signal for nuclear translocation of NF-κB, eventually resulting
in various gene expressions including IL-12 production. IL-12 is
involved in the development of P. acnes-speciﬁc Th1 cells, which
produce robust IFN-γ in response to P. acnes.I L - 1 2a l s oa c t i v a t e s
hepatic NK cells to release IFN-γ.I F N - γ derived from Th1 cells
and NK cells sensitize mice to LPS and induce their dense hepatic
granuloma formation. Administration of NF-κB decoy profoundly
inhibits both the LPS sensitization and the hepatic granuloma
formations [16].
clodronate liposome depletes macrophages in mice, while
control PBS liposome do not aﬀect them [41]. These two
groups of mice are treated with P. acnes,f o l l o w e db yL P S
challenge at day 7. The P. acnes-primed mice depleted of
macrophages show phenotypes similar to na¨ ıve mice after
LPS challenge [38]. They lack liver injury and 100% survive
(Table 1). P. acnes-primed mice receiving PBS liposome,
however, show the susceptibility to LPS similar to that in P.
acnes-primed mice [38]. Thus, macrophages are necessarily
required for the P. acnes-induced sensitization to LPS.
5. Importance of MyD88-IL-12-IFN-γ Axis for
the Sensitization to LPS
It is well established that IFN-γ can potently prime
macrophages to eﬃciently respond to LPS [42]. IFN-γ-
primed macrophages produce much larger amounts of TNF-
α and IL-6 than na¨ ıve cells [32]. Furthermore, Th1 cell
diﬀerentiation occurs both in the liver and spleen after P.
acnestreatmentinamannerdependentonIL-12,aprototype
cytokine for Th1 cell diﬀerentiation [32, 43]. Splenocytes
and splenic CD4+ Tc e l l sf r o mP. acnes-primed WT mice
p r o d u c eal a r g ea m o u n to fI F N - γ but entirely not IL-4 in
response to heat-killed P. acnes and immobilized anti-CD3
mAb, respectively [18, 32]. Besides, splenic CD4+ Tc e l l s
from P. acnes-primed Il12p40
−/− mice do not diﬀerentiate
into Th1 cells [18, 44]. Hepatic CD4+ Tc e l l sd i ﬀerentiate
toward Th1 cells as well, which is totally inhibited by the
treatment with neutralizing anti-IL-12 monoclonal antibody
(mAb) [45]. IL-12 directly activates hepatic NK cells to
produce IFN-γ [46, 47]. Furthermore, hepatic NK cells are
numerically increased and acquire the high responsiveness
to LPS during P. acnes priming phase [48]. From these
observations together, one may assume the importance of
IL-12-IFN-γ axis for the development of LPS sensitization
via induction of Th1 cells. Expectedly, P. acnes-primed
Ifn γ
−/− mice, Il12p40
−/− mice or mice with inherited
unresponsiveness to IL-12 are resistant to LPS, in terms of
lackofhypothermia,hypercoagulationorhighmortality[32,
49]( T a b l e2). In addition, neither Ifn γ
−/− nor Il12p40
−/−
mice form dense hepatic granulomas after P. acnes treatment
[18, 50]( T a b l e2). Thus, IL-12-IFN-γ axis is critical for the
LPS sensitization.
As they cannot actively enter into inside of cells, heat-
killed P. acnes are likely to be recognized by extracellular
sensor TLR. As expected, MyD88, which is a key signal
adapter molecule of the major TLR signal pathway [2],
is essentially required for the development of hepatic
granulomas after P. acnes priming, strongly suggesting
critical role of TLR/MyD88 pathway in the development
of P. acnes-induced LPS sensitization. Myd88
−/− mice lack
hepatic granuloma formation after P. acnes treatment, and
after LPS challenge P. acnes-primed Myd88
−/− mice do
not suﬀer from the mortality or liver injuries [38, 51]
(Table 2, Figure 5). The MyD88-mediated pathway activates
nuclear translocation of NF-κB[ 2]. It is intriguingly to
note that administration of NF-κB decoy during P. acnes
priming phase completely abrogates the hepatic granuloma
formation and the sensitization to LPS in WT mice [16].
This strengthens further the importance of the MyD88-
mediated pathway for the LPS sensitization. Among TLR
members, TLR9 that senses bacterial unmethylated CpG
DNA, but not TLR2 that recognize bacterial cell wall product
peptidoglycan, was clearly veriﬁed to be required for the LPS
sensitization by P. acnes priming [52, 53]. Indeed, P. acnes-
primed Tlr2
−/− mice are comparably susceptible to LPS as P.
acnes-primed WT mice, although P. acnes possess abundant
TLR2 ligands in their cell walls (52). In contrast, P. acnes-
primed Tlr9
−/− mice, like Myd88
−/−mice, fail to develop
hepaticgranulomasandbecomesusceptibletoLPS[53].This
suggests that unmethylated CpG-DNA of P. acnes is pivotal
for the sensitization to LPS at least by P. acnes-priming.
Taken together, these observations strongly suggest that the
MyD88-IL-12-IFN-γ axis plays a pivotal role in the hepatic
granuloma formation and sensitization to LPS (Figure 5).
Upon challenge with TNF-α instead of LPS, P. acnes-
primed WT mice show the manifestations/signs similar to
those of endotoxin shock syndrome [29, 30, 32], indicating
thatTNF-αisaneﬀectorcytokineandthatP. acnes treatment
tremendously facilitates responsiveness to TNF-α.T N F -
α-challenged, P. acnes-primed mice, but not na¨ ıve mice,6 Gastroenterology Research and Practice
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Figure 6: Importance of IL-18 for the development of P. acnes/LPS-induced liver injury. P. acnes-primed wild-type (WT) showed liver
necrosis after LPS challenge. However, treatment with neutralizing anti-IL-18 just before LPS challenge could protect against this liver
injuries [17]. Furthermore, Il18
−/− mice were resistant to the sequential treatment with P. acnes and LPS [18].
Table 1: Clinical manifestations upon LPS challenge. Na¨ ıve mice, P. acnes-primed mice, and P. acnes-primed mice depleted of macrophages
(Mø) were challenged with LPS, and hypothermia, hypercoagulation, lethality and liver injuries were monitored by measurement of rectal
temperaturea, measurement of plasma TAT/PAI-1 levels
b and histological analyses
d.
Systemic alterations Liver injury
d
Mice Hypothermia
a Hypercoagulation
b Lethality (%)c
Na¨ ıve −±0 −
P. acnes-primed Mø-suﬃcient
e +++ +++ 100 +++
Mø-ablated
f ND ND 0 −
a+++ indicates more than 5◦C reduction of rectal temperature after LPS challenge; − indicates less than 1◦Co fi t .
b+++ indicates more than 10μg/ml of plasma TAT levels; − indicates normal range of them (< 50ng/ml); ± indicates less than 200ng/ml.
cMice were monitored for 48 h after LPS challenge.
d+++ indicates more than 300IU of serum ALT levels; − indicates normal range of them (< 50IU).
e P. acnes-primed mice were treated twice with PBS liposome.
f P. acnes-primed mice were treated twice with clodronate liposome to deplete macrophages.
ND; not done
suﬀer from hypothermia with exceptionally high plasma
levels of plasma TAT and PAI-1 and show high mortality.
Consistently, P. acnes-primed Ifn γ
−/− mice are resistant to
TNF-α as well [32]. Thus, P. acnes treatment renders mice
highly susceptible to LPS for TNF-α production and also to
TNF-α itself via induction of IFN-γ production.
6. Importance of IFN-γ for the Systemic
Endotoxin Shock Manifestations after
LPS Challenge
Administration of neutralizing anti-IFN-γ m A bj u s tb e f o r e
LPS challenge could partly rescue P. acnes-primed mice from
hypothermia, hypercoagulation, and high mortality [32],
demonstrating the importance of endogenous IFN-γ for the
accomplishment of LPS phase as well. Taken together, IFN-
γ is a master regulator of the systemic endotoxin shock
syndrome by induction of the sensitization to LPS and
activation of the LPS phase.
7. IL-18 IsNecessary andSufﬁcientfor
the Development of LiverInjuries
Upon LPS challenge many P. acnes-primed WT mice shortly
died, and the surviving mice suﬀer from liver injuries later
(Figure 6). Blockade of IL-18 or genetic depletion of Il18
can protect against the liver damages [17, 54] (Figure 6).
Upon LPS challenge P. acnes-primed Il18
−/− mice having
normally dense hepatic granulomas develop the endotoxin
shock syndrome comparably as P. acnes-primed WT mice
[18]. In contrast, the surviving Il18
−/− mice evade the
liver injuries [18] (Figure 6). These results indicate that
IL-18 is necessary for the development of this liver injury.
Furthermore, administration of IL-18 causes liver injuries in
P. acnes-primedWTmicebutnotna¨ ıvemice[55].Therefore,
IL-18 is necessary and suﬃcient for P. acnes/LPS-induced
liver injury.
IL-18 is capable of inducing hepatocytotoxic TNF-α
d i r e c t l yi nm a n yc e l lt y p e s[ 13]. NK cells and Th1 cells, but
not na¨ ıve CD4+ T cells, express IL-18R [47, 56]. During P.
acnes priming phase, na¨ ıve CD4+ Tc e l l sd i ﬀerentiate into
P. acnes-speciﬁc Th1 cells as described above. Therefore, IL-
18 activates both NK cells and P. acnes-speciﬁc Th1 cells to
produce robust IFN-γ,w h i c hi nt u r nm i g h tf u l l ya c t i v a t e
Kupﬀer cells and hepatic macrophages to further produce
TNF-α [54]. In addition, IL-18 has potent capacity to induce
and upregulate Fas ligand expression on NK cells enough
to kill Fas-expressing hepatocytes [54]. Thus, endogenous
IL-18 participates in the liver injuries through induc-
tion of proinﬂammatory cytokines and cell death-inducing
protein.Gastroenterology Research and Practice 7
Table 2: Importance of IL-12-IFN-γ axis for in vivo LPS sensitization by P. acnes treatment. Mice with various genotypes were sequentially
administered with P. acnes and LPS. At day 7 after P. acnes priming, hepatic granuloma formation was determined by histological analyses.
P. acnes-primed mice Sensitization phase LPS phase
Granuloma formation
a Hypothermia
b Hypercoagulation
c Serum TNF-α
d Lethality
e Liver injury
f
WT +++ +++ +++ +++ 100 +++
Il12p40
−/− −− − − 0 −
Ifn γ
−/− −− − − 0 −
a+++ indicates that 20% and more area of the liver section is occupied by granulomas; − indicates no granulomas.
b+++ indicates more than 5◦C reduction of rectal temperature after LPS challenge; − indicates less than 1◦Co fi t .
c+++ indicates more than 10μg/mL of plasma TAT levels; − indicates normal range of them (< 50ng/mL); ± indicates < 50ng/mL and > 200ng/mL.
d+++ indicates more than 5ng/mL; − indicates less than 0.1ng/mL.
eMice were monitored for 48 h after LPS challenge.
f+++ indicates more than 300IU of serum ALT levels; − indicates normal range of them (< 50IU).
LPS phase
Pro-IL-18
IL-18
Casp1
MyD88
TLR
DAMPs? LPS
TRIF
NLRP3
inﬂammasome
FasL
IFN-γ
TNF-
α
Liver injuries
P2x7R
Figure 7: Molecular and cellular mechanisms for LPS phase. After
challenge of P. acnes-primed wild-type mice with LPS, TLR4 is
activated via TRIF for activation of NLRP3 inﬂammasome, which
eventually leads to cleavage of procaspase-1 into its active form
caspase-1. Active caspase-1, then, processes pro-IL-18 into active
IL-18 for extracellular release. IL-18 upregulates both hepatotoxic
Fas ligand (FasL) expression and TNF-α production. DAMPs
and alarmin released from the injured hepatocytes might further
activate the Kupﬀer cells, eventually resulting in the acceleration
of inﬂammatory responses. DAMPs, damage-associated molecular
patterns.
8.Kupffer CellsSecreteIL-18in
a Manner Dependent on TRIF and
the NLRP3 Inﬂammasome
Many investigators use peritoneal exudate cells (PEC) pre-
pared from the mice administered intraperitoneally with
thioglycorate or bone marrow-derived macrophages (BMM)
by incubation of bone marrow cells with recombinant
monocyte colony-stimulating factor as conventional murine
macrophages. These two types of macrophages cannot
secrete IL-1β or IL-18 after stimulation with LPS alone.
However, LPS-primed PEC or BMM can secrete robust IL-
1β and IL-18 upon subsequent stimulation with exogenous
ATP in a TLR4- and caspase-1-dependent fashion [57, 58].
From these observations the following possibilities have
been believed. First, TLR4-mediated signal pathway cannot
activate caspase-1. Second, ATP signaling via its cell surface
receptor P2x7R is a central event required for the caspase-1
activation in LPS-stimulated macrophages. Third, the TLR4-
mediated signal pathway is only required for induction of
proIL-1β production. We also conﬁrmed the absence of IL-
1β or IL-18 release from LPS-activated PEC or BMM. In
contrasttothesePECandBMM,WTKupﬀercellscanrelease
substantial amounts of IL-1β and IL-18 in response to LPS
or synthetic lipid A (active center of LPS) alone [15, 38, 54,
59]( T a b l e3), strongly suggesting involvement of the TLR4
signaling in release of IL-1β and IL-18. As LPS-stimulated
caspase-1-deﬁcient Kupﬀer cells do not secrete IL-1β or IL-
18 [11, 12], caspase-1 is an essential processing enzyme
of such IL-1β and IL-18. In fact, western blotting analyses
reveal active form of caspase-1 in the lipid A-stimulated
WT Kupﬀer cells [38]( T a b l e3). Expectedly, Tlr4
−/− Kupﬀer
cells fail to activate caspase-1 upon stimulation with lipid
A[ 38]. Thus, Kupﬀer cells seem to be diﬀerent from PEC
or BMM in the ability to activate caspase-1 upon TLR4
engagement. However, it is still to be elucidated how Kupﬀer
cells acquire the potential to activate caspase-1 in response to
TLR4 agonists alone.
The TLR4 signaling is relayed by the MyD88- and TRIF-
mediated pathways [2]. Myd88
−/− Kupﬀer cells stimulated
with TLR4 agonists show normal caspase-1 activation [38].
As the Myd88
−/− Kupﬀer cells cannot produce pro-IL-
1β, eventually resulting in lack of mature IL-1β secre-
tion [38]( T a b l e3). In contrast to proIL-1β,p r o - I L - 1 8i s
constitutively stored in Myd88
−/− Kupﬀe rc e l l sa sw e l la s
WT cells [15]. Therefore, it is convincing that Myd88
−/−
Kupﬀer cells cultured with LPS can secrete IL-18 [15,
38]( T a b l e3). Trif
−/− Kupﬀer cells show the reverse
phenomena. Despite of their normal production of pro-IL-
1β and pro-IL-18, Trif
−/− Kupﬀer cells cannot release IL-
1β or IL-18 due to their inability to activate caspase-1 [38].
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Table 3: Requirement of MyD88 and TRIF for LPS sensitization and Caspase-1 activation, respectively. Mice with various genotypes were
sequentially treated with P. acnes and LPS, and liver specimens and sera were sampled for histological analyses and measurement of IL-
18/IL-1β levels by ELISA, respectively. Kupﬀer cells were incubated with LPS for 4 h, and each supernatant was collected for western blotting
analyses and ELISA. Na¨ ıve mice have no hepatic granulomas or injuries, and their serum IL-18 and iL-1β were undetectable. Na¨ ıve Kupﬀer
cells released no IL-18 and IL-1β.
Genotype
Sensitization phase
Response to LPS
In vivo LPS-stimulated Kupﬀer cells
Western blotting analyses ELISA
Granuloma formation
a Liver injury
b Serum
IL-18/IL-1β
c(ELISA)
ProIL-
1β production
d Active Casp1
e IL-1β/IL-18
release
f
WT +++ +++ +++ +++ +++ +++
Tlr4
−/− +++ −−− − −
Myd88
−/−
−− −− +++ ++g
Trif
−/− +++ −− +++ −−
Casp1
−/− +++ −− +++ −−
Asc
−/− +++ −− +++ −−
Nlrp3
−/− +++ −− ND ND −
P2x7r
−/− +++ +++ +++ +++ +++ +++
a+++ indicates that 20% and more area of the liver section is occupied by granulomas; − indicates no granulomas.
b+++ indicates more than 300IU of serum ALT levels; − indicates normal range of them (< 50IU).
c+++ indicates more than 1000 and 50pg/mL of serum IL-18 and IL-1β levels, respectively; − indicates normal range of them.
d+++ indicates 10 times and more pro-IL-1β density in cell lysates; − indicates the absence of pro-IL-1β.
e+++ indicates the presence of active Caspase-1 (Casp1) in supernatant; − indicates the absence of it.
f+++ indicates more than 100pg/mL; − indicates undetectable levels.
g++ indicates more than 50pg/mL of IL-18, but undetectable IL-1β.
ND; not done
MyD88 in the TLR4-mediated caspase-1 activation (Table 3,
Figure 7).
Asc
−/− Kupﬀer cells have the phenotype similar to
Caspase1−/− cells [38, 60], suggesting that NLRP3 or AIM2
inﬂammasome or unidentiﬁed one that needs ASC protein
(Figure 1) is involved in the caspase-1 activation. Lipid A-
stimulated Nlrp3
−/− Kupﬀe rc e l l sf a i lt os e c r e t eI L - 1 8o r
IL-1β [38]. Therefore, the NLRP3 inﬂammasome activation
is necessary for the TLR4-mediated casapse-1 activation
(Table 3, Figure 7).
These results cannot exclude the possibility that the
TRIF-mediated pathway might cause extracellular release
of ATP and that this self-derived ATP might activate the
NLRP3 inﬂammasome in LPS-stimulated Kupﬀer cells [57,
58]. Unexpectedly, P2x7r
−/− Kupﬀer cells show normal
caspase-1 activation and normal release of IL-1β and
IL-18 [38]. These results demonstrate the dispensabil-
ity of endogenous ATP/P2x7R-mediated pathway for the
TLR4/TRIF/NLRP3-mediated caspase-1 activation (Table 3,
Figure 7).
Although we now know the importance of the NLRP3
inﬂammasome, the precise mechanisms by which the TRIF-
mediatedsignalpathwayactivatestheNLRP3inﬂammasome
is unclear. It is also unknown whether NLRP3 protein
directly recognizes TLR4 agonists. If so, how do the TLR4
agonists translocate into the inside of Kupﬀer cells? Alter-
natively, does TRIF-mediated pathway trigger synthesis of
cytoplasmic NLRP3 agonist? If so, what is the NLRP3
agonist? And, how about the molecular mechanisms for the
TRIF-induced NLRP3 agonist? We need further extensive
studies to address these key queries.
9. Requirement of NLRP3 Inﬂammasome
Activation for the Liver Injury
The capacity to activate caspase-1 reﬂects on the devel-
opment of liver injury [38, 60]. Expectedly, P. acnes-
primed Tlr4
−/− mice, although manifesting normal levels
of hepatic granuloma formation, can avoid the liver injury
after LPS challenge accompanied by lack of serum elevation
of IL-18 (Table 3, Figure 7). Since they fail to develop
hepatic granulomas, P. acnes-primed Myd88
−/− mice lack
the production of robust IL-18 after P. acnes priming,
presumably resulting in escape from the liver injury (Table 3,
Figure 7). This demonstrates again requirement of MyD88
for the P. acnes-induced LPS sensitization. Conversely, P.
acnes-primed Trif
−/− mice, Caspase1−/− mice, Asc
−/− mice
and Nlrp3
−/− mice all have normal dense granulomas
in their livers, but fail to develop liver injury after LPS
challenge, concomitant with the absence of the serum IL-18
increase (Table 3, Figure 7). P2x7r
−/− mice have comparable
p h e n o t y p ea sW Tm i c e( T a b l e3, Figure 7), demonstrating
dispensability of endogenous ATP/P2x7R pathway for the
liver injuries. Thus, the TLR4/TRIF-mediated activation of
NLRP3 inﬂammasome is critical for the development of the
P. acnes/LPS-inducedliverinjuriesviaactivationofcaspase-1
for maturation and release of IL-18.Gastroenterology Research and Practice 9
10. Methods
10.1. Mice. C57BL/6 mice were purchased from Clea Japan
(Osaka, Japan). Female mice (8–12-week-old) were used for
this study. Mice were maintained under speciﬁc pathogen-
free conditions, and received humane care as outlined in
the Guide for the Care and Use of Experimental Animals in
Hyogo College of Medicine.
10.2. Reagents. Monoclonal antibody (mA) against F4/80
of mouse macrophage was purchased from BMA (Augst,
Switzerland). DAPI was from KPL (Gaitherburg, MD).
10.3. Treatment with P. acnes. Heat-killed P. acnes were
labeled with or without Cy3 (GE, Buchinghamshire, UK)
according to the manufacture’s instruction and were injected
into mice through a tail vein. At the indicated time points
varioustissuesandtissuespecimensweresampledforweigh-
ing and analysis of the cellularity by confocal microscopy,
respectively.
10.4. Confocal Microscopic Analysis. Frozen sections of vari-
ous tissues were incubated with mAb against F4/80, biotiny-
lated antirat IgG, and then Alexa Fluor 488-conjugated
streptavidin (Molecular Probes). Nuclei were stained by
DAPI. The immunostaining of each section was evaluated
using a laser scanning confocal microscopy [61, 62].
10.5. Flowcytometry [61]. Spleen cells and Kupﬀer cells were
isolated from variously treated WT B6 mice [55]. Cells were
incubated with APC-conjugated anti-F4/80mAb.
11. Closing Remarks
PAMPsevokeinnate immuneresponses byactivating pattern
recognition receptors (PRRs), such as TLR, NLR, and RLR.
Similarly, injured host cells release endogenous “damage”-
associated molecular patterns (DAMPs) that induce similar
responses via recognition by PRRs [63–65]. For example,
high-mobilitygroupbox1protein(HMGB1)thatislocalized
in the nuclei of various cell types in the steady state
becomes to be extracellularly released upon stimulation of
the cells with death stress. HMGB1, then, initiates innate
immune responses via activating TLR4 [66]. Mitochondria
are endosymbionts derived from certain bacteria during the
evolution of life. Therefore, it is plausible that mitochondria
possess DAMPs homologous to its ancestral PAMPs. Very
recently, this was veriﬁed [67]. Mitochondrion possesses
unmethylated CpG-DNA and formyl peptides similar to
bacterial N-formylated proteins, which are recognized by
PRRs expressed on neutrophils, TLR9, and formyl peptide
receptor,respectively.Intravenousinjectionofthemitochon-
drial DAMPs causes systemic inﬂammatory responses and
lung injuries [67]. As trauma patients have elevated serum
levels of these mitochondrial DAMPs, sterile injury-induced
systemic inﬂammatory response syndrome (SIRS), often
occurring after severe trauma, might undergo in response to
endogenous mitochondrial DAMPs derived from the injured
cells [67]. In addition to DAMPs, self-derived “alarmin” is
proposed as another potent inﬂaming molecules. “Alarmin”
is compartmentalized in certain organelle in the steady state.
Once damaged, cells begin to actively secrete “alarmin”,
which in turn triggers inﬂammatory responses. Intraperi-
toneal injection of dying cells was reported to be able to
trigger peritonitis with dense neutrophil recruitment in an
IL-1α/IL-1R-dependent manner [68]. Furthermore, admin-
istration of acetoaminophen, a common antipyretic, causes
massiveliverinjurywithsterileneutrophilic inﬂammationin
a manner dependent on IL-1α presumably derived from the
damaged hepatocytes as well [68]. Thus, dying cell-derived
IL-1α is regarded as alarmin. Like IL-1α, IL-33 is localized in
thecellnucleiinthesteadystateandisbelievedtobesecreted
after stimulation of the cells with death stress [69]. Histone
proteins derived from cell nuclei play a role as alarmin as
well [70]. These endogenous DAMPs and alarmin might
accelerate liver injuries induced by exogenous PAMPs and
mightbecomenoveltherapeutictargetsforseveresepsiswith
organ failures.
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